1. Home
  2. FATE vs DH Comparison

FATE vs DH Comparison

Compare FATE & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

N/A

Current Price

$2.35

Market Cap

125.6M

Sector

Health Care

ML Signal

N/A

Logo Definitive Healthcare Corp.

DH

Definitive Healthcare Corp.

HOLD

Current Price

$1.00

Market Cap

112.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
FATE
DH
Founded
2007
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
125.6M
112.1M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
FATE
DH
Price
$2.35
$1.00
Analyst Decision
Buy
Hold
Analyst Count
6
5
Target Price
$4.10
$3.08
AVG Volume (30 Days)
1.1M
796.5K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
29.88
63.28
EPS
N/A
N/A
Revenue
$6,646,000.00
$241,521,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.94
$0.61
52 Week High
$3.23
$4.35

Technical Indicators

Market Signals
Indicator
FATE
DH
Relative Strength Index (RSI) 39.71 65.86
Support Level $2.27 $0.93
Resistance Level $2.55 $1.10
Average True Range (ATR) 0.11 0.07
MACD -0.02 0.02
Stochastic Oscillator 0.00 60.35

Price Performance

Historical Comparison
FATE
DH

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: